Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
Akouos Appoints Dr. Kathy Reape as Chief Development Officer
Read Article
News
2021
2020
Archive
April 6, 2021
Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Senor-Based Technologies
April 6, 2021
Artiva Biotherapeutics Appoints Michael E. Faerm as Chief Financial Officer
April 5, 2021
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
April 1, 2021
Scientist.com Partners with Top CROs to Offer Disease Models for Cancer Research
April 1, 2021
Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® and reSET-O® for the Treatment of Substance and Opioid Use Disorders
March 31, 2021
Entrada Therapeutics Announces Closing of $116 Million Series B Financing
March 30, 2021
TMRW Life Sciences Appoints Tara Comonte as Chief Executive Officer
March 23, 2021
IDEAYA Announces Dose Expansion in Phase 1/2 Study of IDE196 and Binimetinib Combination in Metastatic Uveal Melanoma Based on Early Clinical Activity
March 16, 2021
Tufts Health Plan, New England Recovery Center, a Subsidiary of Spectrum Health Systems, and Pear Therapeutics Team Up to Support Members in Recovery from Substance Use Disorder
March 11, 2021
Nouscom Receives Approval to Begin Phase 1B Trials of NOUS-PEV, a Novel Personalized Cancer Immunotherapy
« Previous Page
1
2
3
4
5
…
79
Next Page »
